TG Therapeutics
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Gansevoort St Fl 9, New York, New York...Phone Number
(212) 554-4484Website
www.tgtxinc.comRevenue
$16.1 MillionIndustry
About TG Therapeutics
TG Therapeutics Org Chart
Is TG Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on TG Therapeutics recently announced quarterly report
TG Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if TG Therapeutics had a recent Job posting/layoffs
Check if TG Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once TG Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at TG Therapeutics
Check out if TG Therapeutics is spiking on competitors!
Product Launch: Get notified when TG Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined TG Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
TG Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
TG Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about TG Therapeutics.
TG Therapeutics Tech Stack
A closer look at the technologies used by TG Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TG Therapeutics
TG Therapeutics is dedicated to leveraging scientific advancements to develop innovative treatment options for patients, particularly focusing on multiple sclerosis (MS). The company offers products such as BRIUMVI (ublituximab), which is approved for treating relapsing forms of MS in adults. Their target clients include healthcare providers and pa... Read More